News | March 08, 2007

Blood Replacement may be Just Around the Corner

March 9, 2007 - A way to disinfect blood or even replace it would transform the lives of millions of people, and it's just around the corner.

Bruce Spiess, M.D., a cardiac anesthesiologist at VCU Medical Center in Richmond, Virginia, developed a man-made blood substitute called Oxycyte. It's made from perfluorocarbons (PFCs), a compound similar to non-stick Teflon in frying pans.
He says when you take a carbon atom and add fluoride to it, it can carry a huge amount of oxygen. In a brain injury, swelling makes it tough for red blood cells to carry vital oxygen. Oxycyte's particles are much smaller.

"They are about 1/50th to 1/100 the size of a red blood cell," Dr. Spiess said. Given intravenously, Oxycyte carries oxygen 50-times more effectively than blood. "Within about a half hour to 40 minutes after the patients received the Oxycyte, their brain oxygen levels doubled to quadrupled."

Severe brain injuries kill one in three people. In a study on nine people who got Oxycyte, two died. No survivors had permanent damage.

Oxycyte could also help patients recover from spinal cord injuries, heart attacks and strokes. If it gets FDA approval, it will be the first drug ever approved in the U.S. for traumatic brain injuries.

Related Content

statins, heart scan, CT scan
News | March 25, 2014
As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it...
News | September 30, 2013
A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow...
Feature | February 21, 2013
  Time Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how...
Feature | April 02, 2012
It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most...
News | November 18, 2011
November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic...
News | October 21, 2009
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete...
News | October 05, 2009
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine...
News | July 10, 2009
July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that the way...
News | April 06, 2009
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (...
News | June 16, 2008
June 17, 2008 - One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medic
Overlay Init